Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Domínguez

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|April 20, 2021
Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patientsSilvia Pérez-Pérez, Juan Pablo Cuello, Marisa Martínez-Ginés, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
European Journal of Neurology|October 18, 2021
Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort studyJuan Pablo Cuello, María Luisa Martínez Ginés, José Manuel García Domínguez, et al.
Frontiers in Immunology|July 29, 2021
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple SclerosisCarmen Picón, Amalia Tejeda-Velarde, José Ignacio Fernández-Velasco, et al.
European Journal of Clinical Investigation|March 28, 2022
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19Francisco Javier Redondo-Calvo, Juan Fernando Padín, José Ramón Muñoz-Rodríguez, et al.
International Journal of Radiation Biology|October 14, 2016
Investigation of the influence of calibration practices on cytogenetic laboratory performance for dose estimationFrançois Trompier, Marion Baumann, Lleonard Barrios, et al.
JAMA Neurology|February 27, 2023
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
International Journal of Radiation Biology|October 7, 2016
RENEB - Running the European Network of biological dosimetry and physical retrospective dosimetryUlrike Kulka, Michael Abend, Elizabeth Ainsbury, et al.
International Journal of Radiation Biology|August 26, 2016
RENEB accident simulation exerciseBeata Brzozowska, Elizabeth Ainsbury, Annelot Baert, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|April 20, 2021
Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patientsSilvia Pérez-Pérez, Juan Pablo Cuello, Marisa Martínez-Ginés, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
European Journal of Neurology|October 18, 2021
Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort studyJuan Pablo Cuello, María Luisa Martínez Ginés, José Manuel García Domínguez, et al.
Frontiers in Immunology|July 29, 2021
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple SclerosisCarmen Picón, Amalia Tejeda-Velarde, José Ignacio Fernández-Velasco, et al.
European Journal of Clinical Investigation|March 28, 2022
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19Francisco Javier Redondo-Calvo, Juan Fernando Padín, José Ramón Muñoz-Rodríguez, et al.
International Journal of Radiation Biology|October 14, 2016
Investigation of the influence of calibration practices on cytogenetic laboratory performance for dose estimationFrançois Trompier, Marion Baumann, Lleonard Barrios, et al.
JAMA Neurology|February 27, 2023
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
International Journal of Radiation Biology|October 7, 2016
RENEB - Running the European Network of biological dosimetry and physical retrospective dosimetryUlrike Kulka, Michael Abend, Elizabeth Ainsbury, et al.
International Journal of Radiation Biology|August 26, 2016
RENEB accident simulation exerciseBeata Brzozowska, Elizabeth Ainsbury, Annelot Baert, et al.
Pageof 7